Trial Profile
Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Seizures
- Focus Therapeutic Use
- Acronyms NEST-T_1
- 29 Aug 2012 Planned number of patients changed from 20 to 40.
- 29 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov record.